scispace - formally typeset
G

Giuseppe Paolisso

Researcher at Seconda Università degli Studi di Napoli

Publications -  518
Citations -  36557

Giuseppe Paolisso is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Insulin & Diabetes mellitus. The author has an hindex of 85, co-authored 479 publications receiving 33028 citations. Previous affiliations of Giuseppe Paolisso include National Institutes of Health & University of Udine.

Papers
More filters
Journal ArticleDOI

Implications of AB0 blood group in hypertensive patients with covid-19.

TL;DR: It is indicated that non-0 covid-19 hypertensive patients have significantly higher values of pro-thrombotic indexes, as well as higher rate of cardiac injury and deaths compared to 0 patients, and AB0 blood type influences worse prognosis in hypertensive Patients with covids-19 infection.
Journal ArticleDOI

Greater Efficacy of Pulsatile Insulin in Type I Diabetics Critically Depends on Plasma Glucagon Levels

TL;DR: It is concluded that the greater hypoglycemic effect of insulin administered intravenously in a pulsatile manner in type I diabetics critically depends on plasma glucagon circulating levels.
Journal ArticleDOI

Dipeptidyl peptidase-4 inhibitors in the elderly: more benefits or risks?

TL;DR: The most intriguing therapy for older patients is the one based on the so-called incretins, i.e., gastrointestinal hormones that, mainly secreted in the postprandial phase, stimulate insulin secretion and inhibit glucagon secretion.
Journal ArticleDOI

Effects of different insulin infusion rates on heart rate variability in lean and obese subjects.

TL;DR: In conclusion, insulin stimulates the LF/HF ratio in both lean and obese subjects and thus produces a shift in the cardiac autonomic nervous system activity toward sympathetic predominance.
Journal ArticleDOI

LL-paraoxonase genotype is associated with a more severe degree of homeostasis model assessment IR in healthy subjects.

TL;DR: IR might be the possible missing link between Met-Leu 54 PON polymorphism and the increased cardiovascular risk, independent of age, sex, body mass index, fasting plasma triglycerides, and high-density lipoprotein cholesterol.